TCON

TRACON Pharmaceuticals, Inc. Common Stock

Delisted

TCON was delisted on the 27th of June, 2024.

22 hedge funds and large institutions have $21.1M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$158K
2 +$129K
3 +$93.6K
4
Renaissance Technologies
Renaissance Technologies
New York
+$85.5K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$58.5K

Top Sellers

1 -$1.1M
2 -$490K
3 -$305K
4
QF
QVT Financial
New York
-$157K
5
TC
TFS Capital
Pennsylvania
-$82K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$10.3M
2
$3.38M
3
$3.26M
4
$1.27M
5
$674K
6
$536K
7
$371K
8
$237K
9
$203K
10
$158K
11
$113K
12
$107K
13
$94K
14
$92K
15
$80K
16
$66K
17
$45K
18
$42K
19
$19K
20
$17K
21
$4K
22
$3K
23
24
25